Sign in

CIK 0001367644

  • Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
141902018
Phone
+1 240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 4 Open-market sale Director sold 28,418 shares at an average $111.22 ($3,160,606)
  2. 4 Open-market sale Director sold 4,665 shares at $128.31 ($598,564)
  3. 4 Open-market sale Director sold 6,609 shares at $133.71 ($883,664)
  4. 4 Open-market sale Director sold 6,000 shares at $124.11 ($744,635)
  5. 4 Shares withheld for taxes EVP, Corp Dev, GC & Secretary gave up 1,303 shares (to pay taxes)
  6. 4 Open-market sale Director sold 6,297 shares at $131.00 ($824,907)
  7. 4 Open-market sale Director sold 1,000 shares at $130.27 ($130,270)
  8. 4 Open-market sale Director sold 6,572 shares at $87.51 ($575,142)
  9. 4 Open-market sale Director sold 5,322 shares at $87.50 ($465,691)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Director sold 4,385 shares at $85.15 ($373,373)
  12. 4 Open-market sale Director sold 4,093 shares at $85.10 ($348,322)
  13. 4 Grant or award Director acquired 2,821 shares (grant or award)
  14. 4 Grant or award Director acquired 2,821 shares (grant or award)
  15. 4 Grant or award Director acquired 2,821 shares (grant or award)
  16. 4 Grant or award Director acquired 2,821 shares (grant or award)
  17. 4 Grant or award Director acquired 2,821 shares (grant or award)
  18. 4 Grant or award Director acquired 2,821 shares (grant or award)
  19. 4 Grant or award Director acquired 2,821 shares (grant or award)
  20. 4 Exercise or conversion Director acquired 3,434 shares (option exercise)

Page 14 of 49 · 970 filings